搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
22 小时
AbbVie和Richter扩大中枢神经系统合作伙伴关系,达成新协议
伊利诺伊州北芝加哥 - 艾伯维公司(纽约证券交易所代码:ABBV)和Gedeon Richter Plc.宣布达成协议,共同发现和开发治疗神经精神疾病的新疗法。这项合作建立在近20年的合作伙伴关系基础之上,该合作关系已经产生了中枢神经系统疗法,包括cariprazine(VRAYLAR® / REAGILA®)和研究中的药物ABBV-932。
6 分钟
If You Invested $10,000 In AbbVie Stock 10 Years Ago, How Much Would You Have Now?
AbbVie Inc. (NYSE:ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide. It is set to report its Q3 ...
FierceBiotech
2 小时
AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator
AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...
Emirates247
1 小时
CRISP Program, a new step by AbbVie to foster scientific expertise in the Middle East and ...
AbbVie, a global, research-driven biopharmaceutical company, organized a visit to its R&D facilities—the AbbVie Cambridge ...
bovnews
1 小时
Uncover the Reason: Why AbbVie Inc (ABBV) Stock Is Trading 39.60% Above Its 52-Week Low?
On Thursday, AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $189.65 which represents a slight increase of $1.77 or 0.94% from the prior close of $187.88. The stock opened at $188.43 ...
Pharmaceutical Technology
6 小时
AbbVie and Richter partner for neuropsychiatric treatments
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.
4 小时
Argent Capital Management LLC Has $761,000 Stock Position in AbbVie Inc. (NYSE:ABBV)
Argent Capital Management LLC reduced its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 96.3% in the 3rd quarter, ...
4 小时
American Institute for Advanced Investment Management LLP Boosts Position in AbbVie Inc ...
American Institute for Advanced Investment Management LLP boosted its position in AbbVie Inc. (NYSE:ABBV – Free Report) by ...
Zacks.com on MSN
2 天
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
18 小时
AbbVie, Gedeon Richter collaborate for discovery, development of novel targets
AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...
1 天
AbbVie: Expect A Beat-And-Raise Q3 2024
AbbVie should report strong Q3 2024 results next week and increase the full-year guidance. Explore more details here.
2 天
AbbVie: Balanced Outlook Amid EPS Adjustments and Pipeline Uncertainties Warrants Hold Rating
David Risinger, an analyst from Leerink Partners, maintained the Hold rating on AbbVie (ABBV – Research Report). The associated price ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈